COMMUNIQUÉS West-GlobeNewswire

Yield10 Bioscience to Host Webcast of its 2017 Year-end Conference Call
28/02/2018
WOBURN, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience,Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and host a conference [...]
AzurRx BioPharma to Present at the 30th Annual ROTH Conference (March 12th)
28/02/2018
BROOKLYN, N.Y., Feb. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
28/02/2018
BURLINGTON, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will be participating in seven investor conferences in March. Steven Chehames, Investor Relations, [...]
Invuity Announces Changes to Executive Leadership Team
28/02/2018
Scott D. Flora appointed Interim President and Chief Executive Officer Philip Sawyer steps down as President and Chief Executive Officer SAN FRANCISCO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a [...]
Rockwell Medical Announces Triferic Presentations at the 2018 Annual Dialysis Conference
28/02/2018
Oral and poster presentation of data for Triferic in pediatric patients and patients on intraperitoneal dialysis Conference being held March 3-6, 2018, in Orlando, Fla. WIXOM, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- [...]
OncBioMune Submits Phase 2 Protocol to Urology Centers of North Texas
28/02/2018
BATON ROUGE, La., Feb. 28, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Catalyst Pharmaceuticals Announces Its Continuing Support for Rare Disease Day 2018
28/02/2018
CORAL GABLES, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]
Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
28/02/2018
Long Term Open Label Clinical Results Confirm That FMX101 Appears to be Safe and Well Tolerated; Continued Improvement of Treatment Effect Demonstrated at 52 Weeks Conference Call and Webcast on Wednesday, February 28, [...]
TRHC’s Coding School Accepting Applications for New Veterans Scholarship
28/02/2018
MOUNT PLEASANT, S.C., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (“TRHC”) (NASDAQ: TRHC ) announced today that its code school, JRS Coding School, in Mount Pleasant, SC, is now accepting applications for [...]
Sharecare Co-Founder Dr. Mehmet Oz to Present at The Conference Board’s 18th Annual Employee Health Care Conference in New York
28/02/2018
ATLANTA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced that its co-founder, Dr. Mehmet Oz, will be featured during a special [...]
Premier Biomedical Inc. Searching For Development Partner To Advance Patent Pending Technology
28/02/2018
Jackson Center, PA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC: " BIEI ") announced today they are actively searching for a partner to develop their patented extracorporeal treatment process in [...]
Capricor to Host Key Opinion Leader Lunch on March 9
28/02/2018
LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced it will host a Key Opinion Leader Lunch in New York City on March 9 featuring four distinguished speakers to discuss [...]
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
28/02/2018
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]
Maple Leaf Provides Further Details on the Transfer of its Listing to the Aequitas NEO Exchange Inc.
28/02/2018
CALGARY, Alberta, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSX-V: MGW ) (OTCQB:MGWFF) is pleased to provide further information to the Company’s press release [...]
Aclaris Therapeutics to Webcast Conference Call Discussing Fourth Quarter and Full Year 2017 Financial Results on March 12, 2018
28/02/2018
WAYNE, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and [...]
Actinium Pharmaceuticals Highlights Key Activities and Progress at BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant Organizations
28/02/2018
- Protocol changes to the control arm of the pivotal Phase 3 trial for Iomab-B well received at the Company’s investigator meeting and by Iomab-B’s scientific advisory board - Product theater presentations featuring [...]
Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results
28/02/2018
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ) today announced that it will report financial results for the fourth quarter and full year ended December 31, 2017, after the [...]
Budget 2018: Ovarian cancer research funding still a concern for women
28/02/2018
Toronto, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Advocates pressing for federal investment to address ovarian cancer are today re-iterating the need for specific and targeted investments in ovarian cancer research. While [...]
Budget 2018 : Le financement de la recherche sur le cancer de l’ovaire préoccupe toujours les femmes
28/02/2018
Toronto, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Les porte-parole qui demandaient des investissements fédéraux pour lutter contre le cancer de l’ovaire réitèrent aujourd’hui la nécessité d’investissements spécifiques et [...]

Pages